Subtype
Female Reproductive System Clear Cell Adenocarcinoma
CI-CAN-00005300Explore in graph →
27 active trials
- NCIt
- C222815
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005300Explore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| cBioPortal for Cancer Genomics (public studies) cbioportal | approved | Genomic Cohorts | — | Sep 8, 2026, 01:24 PM UTC |
| CIViC — Clinical Interpretation of Variants in Cancer civic | approved | Evidence | ING-CIVIC-20261001-000001 | Oct 1, 2026, 02:01 AM UTC |
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| PubMed (NCBI E-utilities) pubmed | approved | Literature Counts | ING-PUBMED-20260912-000001 | Sep 12, 2026, 03:00 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| Female Reproductive System Clear Cell Adenocarcinoma | preferred | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.